Table 1 Basic characteristics for patients (a) without DM and (b) with DM
| Â | Whole | HbA1c (%) | P value | |
|---|---|---|---|---|
≤5.7 | >5.7 | |||
(a) | ||||
 Patient number | 272 | 142 | 130 |  |
 Average HbA1c (%) | 5.73 ± 0.76 | 5.46 ± 0.21 | 6.05 ± 0.18 | <0.001 |
 Age (years) | 59.84 ± 10.71 | 59.79 ± 10.44 | 59.90 ± 11.03 | 0.93 |
 Female (%) | 20.96% | 20.28% | 26.15% |  |
 BMI (kg/m2) | 24.81 ± 3.15 | 24.96 ± 3.25 | 24.54 ± 3.02 | 0.4 |
 Current/exsmoker (%) | 57.72% | 60.84% | 56.77% |  |
 Systolic BP (mmHg) | 124.25 ± 20.07 | 124.49 ± 19.19 | 123.78 ± 17.83 | 0.75 |
 DiastolicBP (mmHg) | 77.44 ± 12.56 | 77.36 ± 11.26 | 77.45 ± 10.87 | 0.95 |
 FBG (mg/dL) | 6.05 ± 2.07 | 5.82 ± 1.61 | 6.15 ± 2.24 | 0.23 |
 Ejection fraction (%) | 59.25 ± 19.47 | 59.21 ± 13.01 | 59.12 ± 12.19 | 0.95 |
 LDL-C (mmol/L) | 2.28 ± 0.83 | 2.36 ± 0.72 | 2.19 ± 0.79 | 0.07 |
 Creatine (µmol/L) | 68.54 ± 15.72 | 68.75 ± 16.11 | 68.17 ± 15.19 | 0.76 |
 Previous history of hypertension (%) | 49.63% | 51.05% | 55.20% |  |
 CHF (%) | 6.99% | 7.69% | 6.27% |  |
 Myocardial infarction (%) | 16.18% | 22.38% | 24.74% |  |
 PCI or CABG (%) | 19.49% | 18.88% | 16.64% |  |
 In hospital treatment aspirin (%) | 95.96% | 96.50% | 95.67% |  |
 β-Blocker (%) | 82.72% | 80.42% | 78.66% |  |
 Statin (%) | 93.75% | 97.20% | 97.23% |  |
 CCB (%) | 30.88% | 20.28% | 15.44% |  |
| Â | Whole | HbA1c (%) | P value | |
|---|---|---|---|---|
≤7.1 | >7.1 | |||
(b) | ||||
 Patient number | 137 | 60 | 77 |  |
 Average HbA1c (%) | 7.86 ± 1.56 | 6.53 ± 0.36 | 6.53 ± 0.36 | <0.001 |
 Age (years) | 61.00 ± 10.41 | 57.52 ± 10.15 | 64.05 ± 10.17 | 0.003 |
 DM duration (years) | 4.33 ± 5.91 | 2.83 ± 4.52 | 5.71 ± 6.67 | <0.001 |
 Female (%) | 20.44% | 16.70% | 25.12% |  |
 BMI (kg/m2) | 25.80 ± 2.76 | 25.84 ± 2.57 | 25.78 ± 2.92 | 0.95 |
 Current/exsmoker (%) | 56.20% | 73.29% | 49.73% |  |
 Systolic BP (mmHg) | 127.99 ± 20.45 | 126.18 ± 22.40 | 129.40 ± 18.82 | 0.36 |
 DiastolicBP (mmHg) | 79.47 ± 11.80 | 79.61 ± 12.76 | 79.36 ± 11.07 | 0.9 |
 Fasting plasma glucose | 7.39 ± 2.95 | 7.22 ± 3.08 | 7.54 ± 2.82 | 0.47 |
 Ejection fraction (%) | 56.61 ± 18.07 | 56.73 ± 11.70 | 56.51 ± 11.84 | 0.92 |
 LDL-C (mmol/L) | 2.20 ± 0.93 | 2.35 ± 0.95 | 2.08 ± 0.84 | 0.08 |
 Creatine (µmol/L) | 71.68 ± 28.41 | 69.88 ± 21.91 | 73.08 ± 32.66 | 0.52 |
 Previous history of hypertension (%) | 59.85% | 54.97% | 55.83% |  |
 CHF (%) | 8.03% | 6.69% | 8.36% |  |
 Myocardial infarction (%) | 19.71% | 20.02% | 26.52% |  |
 PCI or CABG (%) | 24.82% | 26.73% | 35.80% |  |
 In hospital treatment aspirin (%) | 98.54% | 40.28% | 97.68% |  |
 β-Blocker (%) | 89.05% | 96.64% | 89.76% |  |
 Statin (%) | 99.27% | 100.00% | 100.00% |  |
 CCB (%) | 27.74% | 21.68% | 27.92% |  |
 Insulin (%) | 17.78% | 13.64% | 21.74% |  |
 Metformin (%) | 0.00% | 0.00% | 0.00% |  |
 Acarbose (%) | 35.56% | 27.27% | 43.48% |  |
 Sulfonylureas (%) | 13.33% | 9.09% | 17.39% |  |